原料药
Sitagliptin Phosphate
KDMF APIs
Sitagliptin Phosphate
韩文名称 | 시타글립틴인산염 |
|---|---|
分类 | 其他代谢类药物 |
CAS No. | 654671-78-0 |
KDMF 登记号 | 수5217-4-ND |
生产厂商 | Mylan Laboratories Limited(Unit-1) |
规格 | In-house |
品目信息
IUPAC Name | (3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one |
|---|---|
Synonyms | Sitagliptin |
Description | Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar. Sitagliptin was granted FDA approval on October 16, 2006. |
Certificate of Analysis | If you need more information, please contact us. |
如需规格书 · 检验成绩书等附加资料，请在咨询时一并提出。负责人确认后将回复您。（02-579-1056 · ace@acebiopharm.com）